WHO Expert Committee on Specifications for Pharmaceutical Preparations : thirty-ninth report.

This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of...

Full description

Saved in:
Bibliographic Details
Superior document:WHO technical report series ; 929
:
TeilnehmendeR:
Year of Publication:2005
Language:English
Series:Technical report series (World Health Organization) ; 929.
Online Access:
Physical Description:vii, 142 p. :; ill.
Notes:"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 500284792
ctrlnum (MiAaPQ)500284792
(Au-PeEL)EBL284792
(CaPaEBR)ebr10120282
(CaONFJC)MIL43616
(OCoLC)476035356
collection bib_alma
record_format marc
spelling WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-ninth report.
Geneva : World Health Organization, 2005.
vii, 142 p. : ill.
WHO technical report series ; 929
"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v.
Includes bibliographical references.
This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Drugs Standards Congresses.
Pharmacopoeias Congresses.
Drugs Quality control Congresses.
Electronic books.
World Health Organization.
WHO Expert Committee on Specifications for Pharmaceutical Preparations (39th : 2004 : Geneva, Switzerland)
ProQuest (Firm)
Technical report series (World Health Organization) ; 929.
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284792 Click to View
language English
format Electronic
eBook
author2 World Health Organization.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
ProQuest (Firm)
author_facet World Health Organization.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
ProQuest (Firm)
World Health Organization.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
ProQuest (Firm)
author2_role TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
author_corporate World Health Organization.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
ProQuest (Firm)
title WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
spellingShingle WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
WHO technical report series ;
title_sub thirty-ninth report.
title_full WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-ninth report.
title_fullStr WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-ninth report.
title_full_unstemmed WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-ninth report.
title_auth WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
title_new WHO Expert Committee on Specifications for Pharmaceutical Preparations
title_sort who expert committee on specifications for pharmaceutical preparations thirty-ninth report.
series WHO technical report series ;
series2 WHO technical report series ;
publisher World Health Organization,
publishDate 2005
physical vii, 142 p. : ill.
callnumber-first R - Medicine
callnumber-subject RA - Public Medicine
callnumber-label RA8
callnumber-sort RA 18 A247 42005
genre Electronic books.
genre_facet Congresses.
Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284792
illustrated Illustrated
oclc_num 476035356
work_keys_str_mv AT worldhealthorganization whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyninthreport
AT whoexpertcommitteeonspecificationsforpharmaceuticalpreparations whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyninthreport
AT proquestfirm whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyninthreport
status_str n
ids_txt_mv (MiAaPQ)500284792
(Au-PeEL)EBL284792
(CaPaEBR)ebr10120282
(CaONFJC)MIL43616
(OCoLC)476035356
hierarchy_parent_title WHO technical report series ; 929
hierarchy_sequence 929.
is_hierarchy_title WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
container_title WHO technical report series ; 929
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1792330675926335489
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02511nam a2200397Ia 4500</leader><controlfield tag="001">500284792</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">051214s2005 sz a sb i100 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9241209291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)500284792</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL284792</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10120282</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL43616</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)476035356</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA8</subfield><subfield code="b">.A247 2005</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">thirty-ninth report.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Geneva :</subfield><subfield code="b">World Health Organization,</subfield><subfield code="c">2005.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">vii, 142 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">WHO technical report series ;</subfield><subfield code="v">929</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacopoeias</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Quality control</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">World Health Organization.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="n">(39th :</subfield><subfield code="d">2004 :</subfield><subfield code="c">Geneva, Switzerland)</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Technical report series (World Health Organization) ;</subfield><subfield code="v">929.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284792</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>